XML 126 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Revenues $ 1,163,314 $ 1,246,929 $ 1,200,211
Operating expenses 835,570 918,673 890,212
Gross margin 327,744 328,256 309,999
Selling, general and administrative expenses 328,214 360,692 348,391
Restructuring and other related charges, net (see Note 16) 1,676 6,727 2,651
Gain on revaluation of contingent consideration 0 (202) (1,174)
Goodwill impairment loss (see Note 1) 0 0 75,241
Operating loss (2,146) (38,961) (115,110)
Interest expense, net 29,713 30,875 21,487
Write-off of deferred loan costs 279 0 1,244
Loss (gain) on convertible debt embedded derivative (see Note 9) 0 24,783 (818)
Other (income) expense, net 715 (410) 510
Loss before income taxes (32,853) (94,209) (137,533)
Less: Benefit for income taxes (see Note 8) (436) (31,063) (53,078)
Net loss $ (32,417) $ (63,146) [1] $ (84,455)
Earnings (Loss) per common share:      
Net income (loss) per share: Basic (in USD per share) $ (1.07) $ (2.10) [1] $ (2.83)
Net income (loss) per share: Diluted (in USD per share) $ (1.07) $ (2.10) [1] $ (2.83)
[1] Income (loss) from continuing operations, net income (loss) and the related earnings (loss) per share amounts for each of the quarters in 2018 are revised from those originally reported to correct errors in income tax expense (benefit) associated with the measurement of valuation allowances on deferred tax assets. Based on an analysis of quantitative and qualitative factors, the Company determined the related impacts were not material to its previously filed interim consolidated financial statements, and therefore, amendments of previously filed reports are not required.